Metronomic capecitabine as extended adjuvant chemotherapy in women with triple negative breast cancer
PURPOSE: High interest in triple-negative breast cancers is not surprising as this category of patients benefits neither from hormonal therapies nor from anti HER2 treatments. Blockade of angiogenesis by metronomic chemotherapy as well as other antiangiogenics might improve outcomes in this group of...
Guardat en:
| Autors principals: | , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Wolters Kluwer Medknow Publications
2015-01-01
|
| Col·lecció: | Hematology/Oncology and Stem Cell Therapy |
| Matèries: | |
| Accés en línia: | https://journals.lww.com/10.1016/j.hemonc.2014.11.003 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|